Posted by Michael Wonder on 03 Aug 2021
GSK files for licensure of MMR vaccine in the US
2 August 2021 - GSK seeks US approval of Priorix vaccine licensed in more than 100 countries.
GSK today announced it has submitted a biologics license application to the US FDA for Priorix (Measles, mumps and rubella Virus vaccine, live) and is seeking approval for use in active immunisation against infection by measles, mumps and rubella.
